A new study, released on the bioRxiv* preprint server, shows that rapamycin, an immunosuppressive drug used in some cancers, and
Continue reading »
mypharmacynews.com
Home »
A new study, released on the bioRxiv* preprint server, shows that rapamycin, an immunosuppressive drug used in some cancers, and
Continue reading »By investigating antibody and T cell responses to a single dose of the Oxford–AstraZeneca COVID-19 vaccine, researchers from Sri Lanka
Continue reading »Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern are characterized by mutations in the receptor-binding domain and
Continue reading »Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern are characterized by mutations in the receptor-binding domain and
Continue reading »The current COVID-19 outbreak is one of the worst pandemics in history and has claimed millions of lives across the
Continue reading »Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative pathogen of the ongoing coronavirus disease 2019 (COVID-19) pandemic. The
Continue reading »Researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital (NRI)
Continue reading »Dr. Andrew Gewirtz, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a four-year federal
Continue reading »The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen successfully uses multiple immune evasion mechanisms to achieve infection within its
Continue reading »Mount Sinai Researchers find a new way to prevent attention deficits associated with Fragile X, a leading genetic cause of
Continue reading »